Back | Next |
home / stock / jspr / jspr message board
Subject | By | Source | When |
---|---|---|---|
Going up to test HOD so prob another | Welsh_Dragon | investorshub | 01/03/2023 7:33:20 PM |
Halt Insiders hilding the majority | IOUBLOKE1 | investorshub | 01/03/2023 7:24:44 PM |
Shaddy how they keeping holding it up I am | ZipCash | investorshub | 01/03/2023 7:00:03 PM |
Wow halt 9 | IOUBLOKE1 | investorshub | 01/03/2023 6:55:40 PM |
#$ABVC next to run big just like $JSPR | ZipCash | investorshub | 01/03/2023 6:29:55 PM |
37 million OS 6.36 FLOAT 91% INSIDERS AND institutiins 212000 short | IOUBLOKE1 | investorshub | 01/03/2023 6:15:20 PM |
Shorts might be coming in to short it | hondaboost | investorshub | 01/03/2023 5:35:59 PM |
$JSPR: FANTASTICCCCCCCCcccccccccccc runner | makinezmoney | investorshub | 01/03/2023 5:30:18 PM |
May be flying to $10. | hondaboost | investorshub | 01/03/2023 5:15:40 PM |
Because the buying are crazy and its rock | hondaboost | investorshub | 01/03/2023 5:14:34 PM |
Digital trading, the MM? Price action gyess cant ajust | IOUBLOKE1 | investorshub | 01/03/2023 3:53:02 PM |
why do they keep halting it? | madras50 | investorshub | 01/03/2023 3:42:12 PM |
Halted again $1.97. 3rd halt already. | Welsh_Dragon | investorshub | 01/03/2023 3:22:16 PM |
Good job I got .99 | Welsh_Dragon | investorshub | 01/03/2023 3:21:48 PM |
i got pre-market $1 on the dot | madras50 | investorshub | 01/03/2023 3:18:14 PM |
Who got pre market under $1 | Welsh_Dragon | investorshub | 01/03/2023 2:31:51 PM |
Turn back the clock | IOUBLOKE1 | investorshub | 01/03/2023 1:09:07 PM |
Wow | Docstemcell2020 | investorshub | 05/17/2022 4:54:47 PM |
znewcar1: JSPR 23% v326K c3.77 f37,8M H4.25 | znewcar1 | investorshangout | 05/03/2022 1:35:06 AM |
Does not look good | Docstemcell2020 | investorshub | 01/14/2022 7:26:36 PM |
News, Short Squeeze, Breakout and More Instantly...
Jasper Therapeutics Inc. Company Name:
JSPR Stock Symbol:
NASDAQ Market:
REDWOOD CITY, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous...
Expanding Portfolio of Mast Cell Programs with Plans to Initiate a Phase 1b/2a study in Patients with Asthma in Q4 2024 Company to Host Key Opinion Leader Webinar on the Potential of Briquilimab in Asthma on May 20, 2024, at 8:00 a.m. EDT REDWOOD CITY, Calif., May 13, 2024 (GLOBE NEWSWI...